Aequus
Aequus is a pharmaceutical company that develops and commercializes therapeutics for the treatment of ophthalmology and neurological disorders.
Business Model: B2C
Revenue: $1.7M
Employees: 2-10
Rankings
Industries / Tags:
Detailed Aequus Information
Geographic Data
Address: 2820-200 Granville Street
City: Vancouver
State: british columbia
Zip: V6C 1S4
Country: CA
Financial Info
Stage:
post ipo equity
Raised Last:
$2M
Raised Total:$10M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Aequus is a pharmaceutical company that develops and commercializes therapeutics for the treatment of ophthalmology and neurological disorders.
Contact Phone:
+16043367906
Contact Email:
Aequus went public on 3/27/2015 on the TMX Group - Toronto Stock Exchange
Listed Exchange:
TMX Group - Toronto Stock Exchange
IPO Date:
3/27/2015
Ticker Symbol:
AQS
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2018 | Post-IPO Equity | $300k | 1/2016 | Post-IPO Equity | $628.8k | 11/2014 | Funding Round | $3.7M | 2/2021 | Private Placement | $1M | 5/2019 | Debt | $2.3M | 8/2018 | Private Placement | $775k | 1/2016 | Private Placement | $1.9M | 11/2014 | Private Placement | $3.7M | 9/2013 | Series A | $1.2M | 8/2020 | Post-IPO Equity | $1.9M | 4/2019 | Post-IPO Debt | $2.2M | 3/2017 | Post-IPO Equity | $3.8M |
|---|
| Announced Date | Name | Price |
|---|---|---|
| 7/2015 | TeOra Health Ltd. |
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
